Induction of a protein-targeted catalytic response in autoimmune prone mice: Antibody-mediated cleavage of HIV-1 glycoprotein GP120

Biochemistry

Volumn 45, Issue 1, 2006, Pages 324-330

  Ponomarenko, Natalia A ^a   Vorobiev, Ivan I ^a   Alexandrova, Elena S ^a,b   Reshetnyak, Andrew V ^c   Telegin, Georgy B ^a   Khaidukov, Sergey V ^a   Avalle, Bérangère ^d   Karavanov, Alexander ^e   Morse III, Herbert C ^f   Thomas, Daniel ^d   Friboulet, Alain ^d   Gabibov, Alexander G ^a,b,c  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^e CIPHERGEN BIOSYSTEMS INC   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CATALYSIS; DEGRADATION; DISEASES; MASS SPECTROMETRY; STRUCTURAL ANALYSIS;

EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE); POLYCLONAL IGG; SDS-PAGE; STRUCTURAL FRAGMENTS;

PROTEINS;

ANTIBODY; ENCEPHALITOGENIC PROTEIN; GLYCOPROTEIN GP 120; HISTIDINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; MYELIN BASIC PROTEIN[85-101]; POLYCLONAL ANTIBODY; SERINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; ANTIBODIES, CATALYTIC; ANTIBODY AFFINITY; AUTOIMMUNE DISEASES; CATALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLUORESCENT DYES; HIV ENVELOPE PROTEIN GP120; HIV-1; IMMUNOGLOBULIN G; LEUCINE; MICE; PEPTIDE FRAGMENTS; PROLINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRAL VACCINES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 30144438492     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050675k     Document Type: Article

References (45)

1. Tang, H., Kuhen, K. L., and Wong-Staal, F. (1999) Lentivirus replication and regulation, Annu. Rev. Genet. 33, 133-170.
2. Burton, D. R., and Parren, P. W. (2000) Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?, Nat. Med. 6, 123-125.
3. Burton, D. R. (1997) A vaccine for HIV type 1: the antibody perspective, Proc. Natl. Acad. Sci. U.S.A. 94, 10018-10023.
4. Poignard, P., Saphire, E. O., Parren, P. W., and Burton, D. R. (2001) gp120: Biologic aspects of structural features, Annu. Rev. Immunol. 19, 253-274.
5. Moore, J. P., and Ho, D. D. (1993) Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans, J. Virol. 67, 863-875.
6. Pollard, S. R., Meier, W., Chow, P., Rosa, J. J., and Wiley, D. C. (1991) CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion, Proc. Natl. Acad. Sci. U.S.A. 88, 11320-11324.
7. Blankson, J. N., Persaud, D., and Siliciano, R. F. (2002) The challenge of viral reservoirs in HIV-1 infection, Annu. Rev. Med. 53, 557-593.
8. Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., Weber, R., Stiegler, G., Vcelar, B., Katinger, H., Aceto, L., and Gunthard, H. F. (2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies, Nat. Med. 11, 615-622.
9. Mets, B., Winger, G., Cabrera, C., Seo, S., Jamdar, S., Yang, G., Zhao, K., Briscoe, R. J., Almonte, R., Woods, J. H., and Landry, D. W. (1998) A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats, Proc. Natl. Acad. Sci. U.S.A. 95, 10176-10181.
10. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Aleksandrova, E. S., Telegin, G. B., Chamborant, O. G., Sidorik, L. L., Suchkov, S. V., Alekberova, Z. S., Gnuchev, N. V., and Gabibov, A. G. (2002) Catalytic antibodies in clinical and experimental pathology: human and mouse models, J. Immunol. Methods 269, 197-211.
11. Nishi, Y. (2002) Evolution of catalytic antibody repertoire in autoimmune mice, J. Immunol. Methods 269, 213-233.
12. Tawfik, D. S., Chap, R., Green, B. S., Sela, M., and Eshhar, Z. (1995) Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? Proc. Natl. Acad. Sci. U.S.A. 92, 2145-2149.
13. Shuster, A. M., Gololobov, G. V., Kvashuk, O. A., Bogomolova, A. E., Smirnov, I. V., and Gabibov, A. G. (1992) DNA hydrolyzing autoantibodies, Science 256, 665-667.
14. Schwartz, R. S. (1993) in Fundamental Immunology (Paul, W. E., Ed.) pp 1033-1097, Raven Press, New York.
15. Paul, S., Volle, D. J., Beach, C. M., Johnson, D. R., Powell, M. J., and Massey, R. J. (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody, Science 244, 1158-1162.
16. Li, L., Paul, S., Tyutyulkova, S., Kazatchkine, M. D., and Kaveri, S. (1995) Catalytic activity of anti-thyroglobulin antibodies, J. Immunol. 154, 3328-3332.
17. Genain, C. P., Cannella, B., Hauser, S. L., and Raine, C. S. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis, Nat. Med. 5, 170-175.
18. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular cloning: a laboratory manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
19. Shioda, T., Oka, S., Xin, X., Liu, H., Harukuni, R., Kurotani, A., Fukushima, M., Hasan, M. K., Shiino, T., Takebe, Y., Iwamoto, A., and Nagai, Y. (1997) In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression, J. Virol. 71, 4871-4881.
20. Harlow, E., and Lane, D. (1988) Antibodies: a laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
21. Murphy, C. I., McIntire, J. R., Davis, D. R., Hodgson, H., Seals, J. R., and Young, E. (1993) Enhanced expression, secretion, and large-scale purification of recombinant HIV-1 gp120 in insect cell using the baculovirus egt and p67 signal peptides, Protein Expression Purif. 4, 349-357.
22. Miller, D., and Karpus, W. J. (1996) Current protocols in immunology (Coligan, J. E., Ed.) Suppl. 19, Unit 15.1, Wiley, New York.
23. Voss, E. W., Jr., Workman, C. J., and Mummert, M. E. (1996) Detection of protease activity using a fluorescence-enhancement globular substrate, BioTechniques 20, 286-291.
24. Yan, J. X., Wait, R., Berkelman, T., Harry, R. A., Westbrook, J. A., Wheeler, C. H., and Dunn, M. J. (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry, Electrophoresis 21, 3666-3672.
25. Swain, S. L. (1999) Helper T cell differentiation, Curr. Opin. Immunol. 11, 180-185.
26. Lyadova, I. V., Eruslanov, E. B., Khaidukov, S. V., Yeremeev, V. V., Majorov, K. B., Pichugin, A. V., Nikonenko, B. V., Kondratieva, T. K., and Apt, A. S. (2000) Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease, J. Immunol. 165, 5921-5931.
27. Carter, L. L., Zhang, X., Dubey, C., Rogers, P., Tsui, L., and Swain, S. L. (1998) Regulation of T cell subsets from naive to memory, J. Immunother. 21, 181-187.
28. Gorny, M. K., VanCott, T. C., Williams, C., Revesz, K., and Zolla-Pazner, S. (2000) Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins, Virology 267, 220-228.
29. Page, K. A., Landau, N. R., and Littman, D. R. (1990) Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity, J. Virol. 64, 5270-5276.
30. Sullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J., and Sodroski, J. (1998) CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization, J. Virol. 72, 4694-4703.
31. Mambetisaeva, E. T., Martin, P. E., and Evans, W. H. (1997) Expression of three functional domains of connexin 32 as thioredoxin fusion proteins in Escherichia coli and generation of antibodies, Protein Expression Purif. 11, 26-34.
32. Pillet, D., Paon, M., Vorobiev, I. I., Gabibov, A. G., Thomas, D., and Friboulet, A. (2002) Idiotypic network mimicry and antibody catalysis: lessons for the elicitation of efficient anti-idiotypic protease antibodies, J. Immunol. Methods 269, 5-12.
33. HIV Sequence Database (2002) Los Alamos National Laboratory.
34. Schultz, P. G., Yin, J., and Lerner, R. A. (2002) The chemistry of the antibody molecule, Angew. Chem., Int. Ed. Engl. 41, 4427-4437.
35. Hilvert, D. (2000) Critical analysis of antibody catalysis, Annu. Rev. Biochem. 69, 751-793.
36. Lacroix-Desmazes, S., Bayry, J., Misra, N., Horn, M. P., Villard, S., Pashov, A., Stieltjes, N., d'Oiron, R., Saint-Remy, J. M., Hoebeke, J., Kazatchkine, M. D., Reinbolt, J., Mohanty, D., and Kaveri, S. V. (2002) The prevalence of proteolytic antibodies against factor VIII in hemophilia A, N. Engl. J. Med. 346, 662-667.
37. Paul, S., Karle, S., Planque, S., Taguchi, H., Salas, M., Nishiyama, Y., Handy, B., Hunter, R., Edmundson, A., and Hanson, C. (2004) Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120, J. Biol. Chem. 279, 39611-39619.
38. Paul, S., Planque, S., Zhou, Y. X., Taguchi, H., Bhatia, G., Karle, S., Hanson, C., and Nishiyama, Y. (2003) Specific HIV gp120-cleaving antibodies induced by covalently reactive analogue of gp120, J. Biol. Chem. 278, 20429-20435.
39. Hifumi, E., Mitsuda, Y., Ohara, K., and Uda, T. (2002) Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chain, J. Immunol. Methods 269, 283-298.
40. Kohen, F., Kim, J. B., Lindner, H. R., Eshhar, Z., and Green, B. (1980) Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten: an esterase-like activity of the antibody-containing site? FEBS Lett. 111, 427-431.
41. Raso, V., and Stollar, B. D. (1975) The antibody-enzyme analogy. Comparison of enzymes and antibodies specific for phosphopyridoxyltyrosine, Biochemistry 14, 591-599.
42. Tramontano, A., Janda, K. D., and Lerner, R. A. (1986) Catalytic antibodies, Science 234, 1566-1570.
43. Kozyr, A. V., Sashchenko, L. P., Kolesnikov, A. V., Zelenova, N. A., Khaidukov, S. V., Ignatova, A. N., Bobik, T. V., Gabibov, A. G., Alekberova, Z. S., Suchkov, S. V., and Gnuchev, N. V. (2002) Anti-DNA autoantibodies reveal toxicity to tumor cell lines, Immunol. Lett. 80, 41-47.
44. Wentworth, P., Jr., McDunn, J. E., Wentworth, A. D., Takeuchi, C., Nieva, J., Jones, T., Bautista, C., Ruedi, J. M., Gutierrez, A., Janda, K. D., Babior, B. M., Eschenmoser, A., and Lerner, R. A. (2002) Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation, Science 298, 2195-2199.
45. Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Hayon-Sonsino, D., Thorenoor, N., Charpentier, J., Luyt, C. E., Mira, J. P., Nagaraja, V., Kazatchkine, M. D., Dhainaut, J. F., and Mallet, V. O. (2005) High levels of catalytic antibodies correlate with favorable outcome in sepsis, Proc. Natl. Acad. Sci. U.S.A. 102, 4109-4113.